Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 405,951 | 34,324 | 36,825 |
| General And Administrative Expense | 395,385 | 34,127 | 36,825 |
| Other Operating Expenses | 47,628 | 23,708 | 13,555 |
| Operating Expense | 453,579 | 58,032 | 50,380 |
| Operating Income | -453,579 | -58,032 | -50,380 |
| EBIT | -453,579 | -58,032 | -50,380 |
| Interest Income | 8,531 | 555.00 | 1,439 |
| Interest Income Non Operating | 8,531 | 555.00 | 1,439 |
| Net Interest Income | 8,531 | 555.00 | 1,439 |
| Other Income Expense | -820,458 | -- | -218.00 |
| Special Income Charges | -820,202 | 0.00 | -- |
| Restructuring And Mergern Acquisition | 820,202 | 0.00 | -- |
| Gain On Sale Of Security | -256.00 | -- | -218.00 |
| Pretax Income | -1.3M | -57,477 | -49,159 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.3M | -57,478 | -49,159 |
| Net Income From Continuing Operation Net Minority Interest | -1.3M | -57,478 | -49,159 |
| Net Income Including Noncontrolling Interests | -1.3M | -57,477 | -49,159 |
| Net Income Common Stockholders | -1.3M | -57,478 | -49,159 |
| Net Income | -1.3M | -57,478 | -49,159 |
| EBITDA | -453,579 | -58,032 | -50,380 |
| Normalized EBITDA | 366,879 | -58,032 | -50,162 |
| Basic EPS | -0.03 | -0.00 | -0.00 |
| Diluted EPS | -0.03 | -0.00 | -0.00 |
| Basic Average Shares | 34.8M | 34.0M | 34.0M |
| Diluted Average Shares | 34.8M | 34.0M | 34.0M |
| Total Unusual Items | -820,458 | 0.00 | -218.00 |
| Total Unusual Items Excluding Goodwill | -820,458 | 0.00 | -218.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 |
| Normalized Income | -445,048 | -57,478 | -48,941 |
| Diluted NI Availto Com Stockholders | -1.3M | -57,478 | -49,159 |
| Impairment Of Capital Assets | 0.00 | 0.00 | -- |
| Net Income Continuous Operations | -1.3M | -57,477 | -49,159 |
| Net Non Operating Interest Income Expense | 8,531 | 555.00 | 1,439 |
| Other Gand A | 395,385 | 34,127 | 36,825 |
| Selling And Marketing Expense | 10,566 | 197.00 | -- |
| Total Expenses | 453,579 | 58,032 | 50,380 |
| Line Item | Q3 2025Sep 30, 2025 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|
| Cash And Cash Equivalents | 2.3M | -- | 122,082 |
| Cash Cash Equivalents And Short Term Investments | 2.3M | -- | 122,082 |
| Cash Financial | 2.3M | -- | 122,082 |
| Accounts Receivable | -- | -- | 1,000 |
| Receivables | -- | -- | 1,000 |
| Prepaid Assets | 30,000 | -- | -- |
| Current Assets | 2.3M | -- | 123,082 |
| Net PPE | 75,000 | -- | 25,000 |
| Total Non Current Assets | 75,000 | -- | 25,000 |
| Total Assets | 2.4M | -- | 148,082 |
| Accounts Payable | 101,501 | -- | 54,766 |
| Payables | 101,501 | -- | 54,766 |
| Payables And Accrued Expenses | 121,501 | -- | 89,766 |
| Current Accrued Expenses | 20,000 | -- | 35,000 |
| Current Liabilities | 121,501 | -- | 89,766 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | -- | 0.00 |
| Total Liabilities Net Minority Interest | 121,501 | -- | 89,766 |
| Common Stock | 3.8M | -- | 258,750 |
| Capital Stock | 3.8M | -- | 258,750 |
| Retained Earnings | -1.6M | -- | -200,434 |
| Gains Losses Not Affecting Retained Earnings | 108,035 | -- | -- |
| Other Equity Adjustments | 108,035 | -- | -- |
| Common Stock Equity | 2.2M | -- | 58,316 |
| Stockholders Equity | 2.2M | -- | 58,316 |
| Total Equity Gross Minority Interest | 2.2M | -- | 58,316 |
| Total Capitalization | 2.2M | -- | 58,316 |
| Net Tangible Assets | 2.2M | -- | 58,316 |
| Tangible Book Value | 2.2M | -- | 58,316 |
| Working Capital | 2.2M | -- | 33,316 |
| Invested Capital | 2.2M | -- | 58,316 |
| Share Issued | 45.6M | -- | 34.0M |
| Ordinary Shares Number | 45.6M | -- | 34.0M |
| Line Item | Q3 2025Sep 30, 2025 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|
| Operating Cash Flow | -- | -40,381 | -- |
| Cash Flow From Continuing Operating Activities | -- | -40,381 | -- |
| Change In Working Capital | -- | 6,899 | -- |
| Change In Payables And Accrued Expense | -- | 5,899 | -- |
| Purchase Of PPE | -- | -16,506 | -- |
| Net PPE Purchase And Sale | -- | -16,506 | -- |
| Investing Cash Flow | -- | -16,506 | -- |
| Cash Flow From Continuing Investing Activities | -- | -16,506 | -- |
| Changes In Cash | -- | -56,887 | -- |
| Beginning Cash Position | -- | 122,082 | -- |
| End Cash Position | -- | 65,195 | -- |
| Free Cash Flow | -- | -56,887 | -- |
| Net Income From Continuing Operations | -- | -78,786 | -- |